Swiss Cannabis Trials Show How Politics Shapes Drug Policy Research

Social forces, including political imperatives and stakeholder interests, collectively shaped the Swiss cannabis pilot trial research. Informants committed to rigorous research while acknowledging that harm reduction discourse, power asymmetries, and political context influenced study design and implementation. The result was evidence production adjusted to align with contextual realities rather than purely scientific considerations.

Qualitative study using thematic content analysis of semi-structured interviews with 18 stakeholders including scientists, policymakers, pharmacists, physicians, cannabis producers, and public health officials involved in Swiss cannabis pilot trials.

Drug policy is increasingly claimed to be "evidence-based," but this study reveals how the evidence itself is shaped by political and social forces. Understanding this dynamic is crucial for interpreting drug policy research and designing truly independent studies.

The concept of "policy-based evidence" (where policy needs shape the evidence that gets produced, rather than evidence shaping policy) has implications far beyond cannabis. This case study provides a concrete example of how this works in practice.

Qualitative study from one country's specific regulatory context. Stakeholder perspectives may be self-serving or biased. The small sample may not capture all relevant viewpoints. Findings about Swiss pilot trials may not generalize to other countries.